Tag Archives: FRPT

Top Blue Chip Stocks For 2019

&l;p&g;&l;img class=&q;dam-image shutterstock size-large wp-image-1106738453&q; src=&q;https://specials-images.forbesimg.com/dam/imageserve/1106738453/960×0.jpg?fit=scale&q; data-height=&q;640&q; data-width=&q;960&q;&g; Shutterstock

What if I told you there&a;rsquo;s a way you can buy your favorite blue chips and get a dividend &l;i&g;up to 6 times bigger&l;/i&g; than what these stocks pay today?

Let&a;rsquo;s be honest: with an income stream like that, backed by household names like &l;b&g;Pfizer &l;/b&g;and &l;b&g;AT&a;amp;T&l;/b&g;&a;mdash;more on these two stocks below&a;mdash;you&a;rsquo;d leap at the chance, right?

The truth is, you&a;rsquo;d be crazy not to.

Well, now you can. And today I&a;rsquo;m going to show you exactly how to do it&a;mdash;and 2 quick moves to get you there instantly.

&l;b&g;Like Buying Cheap in 2009 &a;hellip; and Knowing What Happens Next&l;/b&g;

Funny thing is, for a brief, shining moment in the not-so-distant past (early March 2009), many blue chips actually &l;i&g;did&l;/i&g; deliver payouts of 7%, 10% and more.

Top Blue Chip Stocks For 2019: Freshpet, Inc.(FRPT)

Advisors’ Opinion:

  • [By Logan Wallace]

    Freshpet (NASDAQ:FRPT) – Research analysts at William Blair reduced their Q2 2018 earnings estimates for shares of Freshpet in a research note issued to investors on Monday, May 7th. William Blair analyst J. Andersen now expects that the company will post earnings per share of ($0.09) for the quarter, down from their prior forecast of ($0.04). William Blair also issued estimates for Freshpet’s Q4 2018 earnings at $0.10 EPS and FY2018 earnings at ($0.07) EPS.

  • [By Max Byerly]

    Shares of Freshpet Inc (NASDAQ:FRPT) have been assigned a consensus rating of “Buy” from the eleven research firms that are presently covering the firm, Marketbeat Ratings reports. Five analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and two have given a strong buy recommendation to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $20.60.

  • [By Jon C. Ogg]

    Freshpet Inc. (NASDAQ: FRPT) was maintained as Neutral but the target price was raised to $36 from $32 at Credit Suisse.

    Harpoon Therapeutics Inc. (NASDAQ: HARP) was started as Outperform and assigned a $23 price target (versus a $17.01 close) at Wedbush Securities.

  • [By Motley Fool Transcribers]

    Freshpet Inc  (NASDAQ:FRPT)Q4 2018 Earnings Conference CallFeb. 26, 2019, 4:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Top Blue Chip Stocks For 2019: Alaska Air Group, Inc.(ALK)

Advisors’ Opinion:

  • [By Adam Levine-Weinberg]

    The oil rally has cooled off this month, over recent reports that have alleviated investors’ worries about a serious oil shortage. Lower jet fuel prices should help all of the airlines, but two could benefit disproportionately: Spirit Airlines (NYSE:SAVE) and Alaska Air (NYSE:ALK).

  • [By Adam Levine-Weinberg]

    The last couple of years have not been kind to JetBlue Airways (NASDAQ:JBLU) and Alaska Air Group (NYSE:ALK). Rising fuel prices have pinched profitability across the U.S. airline industry, but due to competitive dynamics and other factors, JetBlue and Alaska have had more trouble offsetting these cost headwinds than some other carriers.

  • [By Todd Shriber, ETF Professor]

    The analyst highlighted American Airlines Group Inc. (NASDAQ: AAL), Delta Airlines Inc. (NYSE: DAL), Southwest Airlines Co. (NYSE: LUV) and Alaska Air Group Inc. (NASDAQ: ALK) as among the industry's best-positioned names. The quartet combines for over 38 percent of JETS' roster.

Top Blue Chip Stocks For 2019: Sarepta Therapeutics, Inc.(SRPT)

Advisors’ Opinion:

  • [By ]

    Some of my readers may know Sarepta (Nasdaq: SRPT) well. This $9 billion gene-therapy company already has an FDA-approved product. Exondys 51, the first-ever FDA-approved treatment for a rare but deadly genetic disease called Duchenne muscular dystrophy (DMD), is already on the market. And just last month, the FDA granted priority review for SRPT’s second treatment for DMD, golodirsen, for DMD patients with a different genetic mutation.

  • [By WWW.GURUFOCUS.COM]

    For the details of ETF Portfolio Partners, Inc.’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=ETF+Portfolio+Partners%2C+Inc.

    These are the top 5 holdings of ETF Portfolio Partners, Inc.Vanguard Total Stock Market (VTI) – 194,472 shares, 17.91% of the total portfolio. Shares added by 1.13%iShares Core U.S. Aggregate Bond (AGG) – 254,189 shares, 17.72% of the total portfolio. Shares added by 3.15%iShares Russell 1000 (IWB) – 98,181 shares, 9.78% of the total portfolio. Shares added by 0.56%Vanguard FTSE Developed Markets (VEA) – 322,914 shares, 9.08% of the total portfolio. Shares added by 1.20%iShares S&P 500 Value (IVE) – 108,531

  • [By Keith Speights]

    Three biotech stocks — Solid Biosciences (NASDAQ:SLDB), Sarepta Therapeutics (NASDAQ:SRPT), and Heron Therapeutics (NASDAQ:HRTX) — soared this week by 30% or more thanks to news that brought smiles to investors’ faces. Here’s what drove these stocks higher and whether or not they’re smart picks to buy now.

  • [By Angelica LaVito]

    CAMBRIDGE, Mass.,June 19, 2018 (GLOBE NEWSWIRE) –Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare neuromuscular diseases, announced that at the Company’s R&D Day,Jerry Mendell, M.D. of Nationwide Children’s Hospital presented positive preliminary results from its Phase 1/2a gene therapy clinical trial assessing AAVrh74.MHCK7.micro-Dystrophin in individuals with Duchenne muscular dystrophy (DMD). Dr. Mendell presented the following preliminary data on the first three patients enrolled in the study:

Top Blue Chip Stocks For 2019: UFP Technologies Inc.(UFPT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    UFP Technologies (NASDAQ: UFPT) and China XD Plastics (NASDAQ:CXDC) are both small-cap industrial products companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, risk, profitability and earnings.

  • [By Ethan Ryder]

    Media coverage about UFP Technologies (NASDAQ:UFPT) has trended somewhat positive recently, Accern Sentiment Analysis reports. The research group identifies positive and negative press coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. UFP Technologies earned a daily sentiment score of 0.03 on Accern’s scale. Accern also assigned headlines about the industrial products company an impact score of 47.0533500754779 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

  • [By Logan Wallace]

    China XD Plastics (NASDAQ: CXDC) and UFP Technologies (NASDAQ:UFPT) are both small-cap basic materials companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, institutional ownership, earnings, risk and valuation.

Top 5 Medical Stocks To Buy For 2019

Canada-based marijuana grower Tilray Inc. (NASDAQ: TLRY) added nearly 30% to its share price on Tuesday to close at $154.98, after posting a new post-IPO high of $155.10. In Wednesday’s premarket trading, Tilray soared another 40% to trade at more than $215 a share.

The company had sales of $9.7 million in the June quarter and a market cap of nearly $14.5 billion following Tuesday’s share price jump. Tilray’s quarterly loss came to nearly $11 million ($0.17 per share on a GAAP basis).

Tuesday’s big move was the result of the announced approval by the U.S. Drug Enforcement Agency (DEA) for Tilray to export cannabis to the United States for medical research purposes. A week earlier the company received approval to export medical cannabis flower to Germany. Tilray already had gained approval to export cannabis-derived oils to Germany.

Marijuana for legal recreational and adult use goes on sale next month in Canada, and that could drive Tilray sales higher. The company has struck deals with some Canadian firms to supply marijuana for use in recreational and adult-use products. But that hardly seems to justify the nosebleed share price levels.

Top 5 Medical Stocks To Buy For 2019: Topdanmark A/S (TOP)

Advisors’ Opinion:

  • [By Logan Wallace]

    TopCoin (CURRENCY:TOP) traded down 15.4% against the dollar during the 1-day period ending at 7:00 AM E.T. on June 21st. During the last seven days, TopCoin has traded up 4% against the dollar. TopCoin has a market cap of $0.00 and approximately $123.00 worth of TopCoin was traded on exchanges in the last day. One TopCoin coin can currently be bought for about $0.0010 or 0.00000015 BTC on popular exchanges.

  • [By Max Byerly]

    TopCoin (CURRENCY:TOP) traded flat against the U.S. dollar during the one day period ending at 7:00 AM E.T. on September 8th. In the last seven days, TopCoin has traded flat against the U.S. dollar. TopCoin has a total market capitalization of $0.00 and $0.00 worth of TopCoin was traded on exchanges in the last day. One TopCoin coin can now be bought for about $0.0008 or 0.00000010 BTC on major cryptocurrency exchanges.

Top 5 Medical Stocks To Buy For 2019: Preferred Apartment Communities, Inc.(APTS)

Advisors’ Opinion:

  • [By Logan Wallace]

    Headlines about Preferred Apartment Communities (NYSE:APTS) have trended somewhat positive this week, according to Accern. The research firm ranks the sentiment of press coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Preferred Apartment Communities earned a media sentiment score of 0.16 on Accern’s scale. Accern also assigned news stories about the real estate investment trust an impact score of 45.8928811434586 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

  • [By Max Byerly]

    WINTON GROUP Ltd acquired a new stake in Preferred Apartment Communities Inc. (NYSE:APTS) during the 1st quarter, Holdings Channel reports. The firm acquired 80,485 shares of the real estate investment trust’s stock, valued at approximately $1,142,000.

  • [By Ethan Ryder]

    Stratos Wealth Partners LTD. lifted its stake in shares of Preferred Apartment Communities Inc. (NYSE:APTS) by 135.8% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 14,089 shares of the real estate investment trust’s stock after purchasing an additional 8,113 shares during the quarter. Stratos Wealth Partners LTD.’s holdings in Preferred Apartment Communities were worth $200,000 as of its most recent SEC filing.

Top 5 Medical Stocks To Buy For 2019: Freshpet, Inc.(FRPT)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Petmed Express and pet stock peer Central Garden & Pet Co (NASDAQ: CENT) being outstanding performers over the last year or two while pet food stocks Blue Buffalo Pet Products Inc (NASDAQ: BUFF) and Freshpet Inc (NASDAQ: FRPT) have not yet lived up to investor expectations:

  • [By Joseph Griffin]

    OLD National Bancorp IN trimmed its stake in shares of Freshpet Inc (NASDAQ:FRPT) by 26.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 6,580 shares of the company’s stock after selling 2,315 shares during the quarter. OLD National Bancorp IN’s holdings in Freshpet were worth $212,000 at the end of the most recent quarter.

  • [By Lisa Levin]

    On Friday, the consumer staples shares surged 0.62 percent. Meanwhile, top gainers in the sector included Universal Corporation (NYSE: UVV), up 5 percent, and Freshpet, Inc. (NASDAQ: FRPT) up 4 percent.

  • [By Max Byerly]

    Shares of Freshpet Inc (NASDAQ:FRPT) have been assigned a consensus rating of “Buy” from the eleven research firms that are presently covering the firm, Marketbeat Ratings reports. Five analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and two have given a strong buy recommendation to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $20.60.

  • [By Logan Wallace]

    Freshpet (NASDAQ:FRPT) – Research analysts at William Blair reduced their Q2 2018 earnings estimates for shares of Freshpet in a research note issued to investors on Monday, May 7th. William Blair analyst J. Andersen now expects that the company will post earnings per share of ($0.09) for the quarter, down from their prior forecast of ($0.04). William Blair also issued estimates for Freshpet’s Q4 2018 earnings at $0.10 EPS and FY2018 earnings at ($0.07) EPS.

  • [By Ethan Ryder]

    Freshpet Inc (NASDAQ:FRPT) reached a new 52-week high and low during trading on Tuesday . The company traded as low as $22.75 and last traded at $22.65, with a volume of 5950 shares trading hands. The stock had previously closed at $22.35.

Top 5 Medical Stocks To Buy For 2019: ZAIS Group Holdings, Inc.(ZAIS)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Gp Zgp (NASDAQ:ZAIS) major shareholder Z Acquisition Llc bought 6,500,000 shares of the company’s stock in a transaction on Wednesday, September 5th. The stock was bought at an average price of $4.10 per share, with a total value of $26,650,000.00. Following the completion of the acquisition, the insider now owns 6,500,000 shares in the company, valued at $26,650,000. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Major shareholders that own more than 10% of a company’s stock are required to disclose their transactions with the SEC.

Top 5 Medical Stocks To Buy For 2019: Special Opportunities Fund Inc.(SPE)

Advisors’ Opinion:

  • [By Max Byerly]

    Spartan Energy (TSE:SPE) insider Albert Jason Stark sold 21,706 shares of Spartan Energy stock in a transaction dated Tuesday, May 8th. The stock was sold at an average price of C$6.48, for a total transaction of C$140,654.88.

  • [By Ethan Ryder]

    Special Opportunities Fund, Inc. (NYSE:SPE) insider Gerald Hellerman bought 1,000 shares of the firm’s stock in a transaction on Thursday, October 11th. The stock was purchased at an average cost of $14.47 per share, with a total value of $14,470.00. Following the completion of the transaction, the insider now directly owns 22,793 shares of the company’s stock, valued at $329,814.71. The transaction was disclosed in a filing with the SEC, which is available through this link.

Hot Heal Care Stocks To Invest In 2019

Synchrony Financial (NYSE: SYF) and Green Dot (NYSE:GDOT) are both finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, risk, institutional ownership, profitability, analyst recommendations, valuation and dividends.

Analyst Ratings

Get Synchrony Financial alerts:

This is a summary of current ratings and recommmendations for Synchrony Financial and Green Dot, as reported by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Synchrony Financial 1 4 10 0 2.60
Green Dot 0 5 8 0 2.62

Synchrony Financial currently has a consensus price target of $40.79, indicating a potential upside of 24.31%. Green Dot has a consensus price target of $70.17, indicating a potential downside of 14.13%. Given Synchrony Financial’s higher possible upside, equities analysts plainly believe Synchrony Financial is more favorable than Green Dot.

Hot Heal Care Stocks To Invest In 2019: Apple Hospitality REIT, Inc.(APLE)

Advisors’ Opinion:

  • [By Shane Hupp]

    Riverhead Capital Management LLC grew its position in Apple Hospitality REIT (NYSE:APLE) by 607.7% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 134,100 shares of the real estate investment trust’s stock after acquiring an additional 115,150 shares during the quarter. Riverhead Capital Management LLC owned about 0.06% of Apple Hospitality REIT worth $2,356,000 at the end of the most recent reporting period.

  • [By Lee Jackson]

    Apple Hospitality REIT Inc. (NYSE: APLE) owns one of the largest portfolios of upscale, select-service hotels in the United States. Investors are paid a generous 6.67% yield. The shares traded at $17.95 early Thursday, in a 52-week range of $16.72 to $21.90. The consensus price objective is $19.25.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Apple Hospitality REIT (APLE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Apple Hospitality REIT Inc (NYSE:APLE) reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $16.67 and last traded at $16.70, with a volume of 40427 shares trading hands. The stock had previously closed at $16.88.

  • [By Stephan Byrd]

    Headlines about Apple Hospitality REIT (NYSE:APLE) have been trending positive on Saturday, Accern reports. The research firm identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Apple Hospitality REIT earned a media sentiment score of 0.31 on Accern’s scale. Accern also assigned media stories about the real estate investment trust an impact score of 46.3188845387547 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Apple Hospitality REIT (APLE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Hot Heal Care Stocks To Invest In 2019: Discovery Communications, Inc.(DISCB)

Advisors’ Opinion:

  • [By Billy Duberstein]

    Discovery, Inc. (NASDAQ:DISCA) (NASDAQ:DISCB) (NASDAQ:DISCK) has traded very cheaply over the past few years. As more and more U.S. consumers “cut the cord” on the traditional cable bundle, Discovery’s channels (which now include all Scripps Networks Interactive channels) have seen their subscriber counts decline. That, combined with the high debt load incurred for the company’s 2017 acquisition of Scripps Networks Interactive, sent investors running for the hills last year. In 2017, the company’s three share classes dropped from roughly 10% to roughly 21%.

  • [By Billy Duberstein]

    You might think Discovery Inc.’s (NASDAQ:DISCA) (NASDAQ:DISCK) (NASDAQ:DISCB) stations primarily feature nature videos and celebrity cooks, but did you know it’s actually becoming a player on the international sports scene? While known for its namesake Discovery Channel and documentary brands such as The Learning Channel, HGTV, and the Food Network, Discovery has actually been in the sports business since 2012, when it first acquired a minority stake in European sports channel Eurosport. Discovery was apparently pleased enough with the channel’s progress to buy 100% of Eurosport in July 2015, and that year, Eurosport won the exclusive rights to broadcast the Olympics in Europe from 2018-2022.

  • [By Max Byerly]

    Discovery (NASDAQ:DISCB) announced its quarterly earnings results on Tuesday. The company reported $0.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.13, Morningstar.com reports. Discovery had a negative net margin of 7.40% and a positive return on equity of 19.34%. The company had revenue of $2.31 billion for the quarter.

Hot Heal Care Stocks To Invest In 2019: Teva Pharmaceutical Industries Limited(TEVA)

Advisors’ Opinion:

  • [By Todd Campbell]

    Although Allergan forecast free cash flow of $8 billion in 2016 that would allow it to “rapidly de-lever the balance sheet,” it didn’t quite work out that way. Under pressure following Valeant’s fall from grace, Allergan announced in mid-2015 it would sell Actavis’ legacy generic-drug business to Teva Pharmaceutical (NYSE:TEVA) for $40.5 billion, including $33.75 billion in cash, a move that would allow it to reduce its debt far faster than it would’ve been able to otherwise. Following that announcement, rumors began swirling that Pfizer (NYSE:PFE) wanted to acquire Allergan to capture tax savings associated with Allergan’s being domiciled in low-tax Ireland, rather than the United States, where taxes were much higher. Allergan confirmed those rumors in October and soon after announced a massive $160 billion deal that valued Allergan’s shares at $363.63 each. 

  • [By Todd Campbell, Sean Williams, and Brian Feroldi]

    There have been more stock market pops and drops lately and that might have you wondering what healthcare stocks can be bought to take advantage of this volatility. Buying healthcare stocks during periods of volatility can be smart because demand for healthcare products and services usually isn’t discretionary. However, that doesn’t necessarily mean it makes sense to buy every healthcare stock out there. To find out what healthcare stocks it might make sense to buy this month, we asked top Motley Fool investors what companies are on their radar. In their view, Teva Pharmaceutical Industries (NYSE:TEVA), Novacure (NASDAQ:NVCR), and Galapagos (NASDAQ:GLPG) should be at the top of your idea list right now. Read on to find out why.

  • [By Timothy Green, Nicholas Rossolillo, and Todd Campbell]

    Occasionally, a growth stock falls out of favor. When that happens, the stock may start looking more like a value stock, even though the above-average growth potential is still there. Three of our Motley Fool contributors think Cypress Semiconductor (NASDAQ:CY), Skechers (NYSE:SKX), and Teva Pharmaceutical (NYSE:TEVA) fall into this category. Here’s what you need to know about these deep-value growth stocks.

  • [By Keith Speights]

    Teva Pharmaceutical Industries (NYSE:TEVA) made more than $3.1 billion in the U.S. last year with Copaxone. In addition, the drug generated sales outside the U.S. of around $700 million. Sales for Copaxone, however, are declining in the face of generic competition.

Hot Heal Care Stocks To Invest In 2019: Black Hills Corporation(BKHU)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Media headlines about BLACK HILLS Cor/EQUITY Ut (NYSE:BKHU) have trended positive recently, Accern reports. The research firm identifies positive and negative news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. BLACK HILLS Cor/EQUITY Ut earned a daily sentiment score of 0.30 on Accern’s scale. Accern also assigned media stories about the company an impact score of 44.7211950698084 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Hot Heal Care Stocks To Invest In 2019: Freshpet, Inc.(FRPT)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of Petmed Express and pet stock peer Central Garden & Pet Co (NASDAQ: CENT) being outstanding performers over the last year or two while pet food stocks Blue Buffalo Pet Products Inc (NASDAQ: BUFF) and Freshpet Inc (NASDAQ: FRPT) have not yet lived up to investor expectations:

  • [By Lisa Levin]

    On Friday, the consumer staples shares surged 0.62 percent. Meanwhile, top gainers in the sector included Universal Corporation (NYSE: UVV), up 5 percent, and Freshpet, Inc. (NASDAQ: FRPT) up 4 percent.

  • [By Max Byerly]

    Shares of Freshpet Inc (NASDAQ:FRPT) have been assigned a consensus rating of “Buy” from the eleven research firms that are presently covering the firm, Marketbeat Ratings reports. Five analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and two have given a strong buy recommendation to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $20.60.

  • [By Ethan Ryder]

    Freshpet Inc (NASDAQ:FRPT) reached a new 52-week high and low during trading on Tuesday . The company traded as low as $22.75 and last traded at $22.65, with a volume of 5950 shares trading hands. The stock had previously closed at $22.35.

  • [By Logan Wallace]

    Freshpet (NASDAQ:FRPT) – Research analysts at William Blair reduced their Q2 2018 earnings estimates for shares of Freshpet in a research note issued to investors on Monday, May 7th. William Blair analyst J. Andersen now expects that the company will post earnings per share of ($0.09) for the quarter, down from their prior forecast of ($0.04). William Blair also issued estimates for Freshpet’s Q4 2018 earnings at $0.10 EPS and FY2018 earnings at ($0.07) EPS.

Hot Heal Care Stocks To Invest In 2019: Snap-On Incorporated(SNA)

Advisors’ Opinion:

  • [By Max Byerly]

    News stories about Snap-on (NYSE:SNA) have been trending somewhat positive recently, according to Accern Sentiment Analysis. The research group identifies positive and negative press coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Snap-on earned a coverage optimism score of 0.14 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 47.1849288529918 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Stephan Byrd]

    Bronfman E.L. Rothschild L.P. decreased its position in Snap-on Incorporated (NYSE:SNA) by 62.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 623 shares of the company’s stock after selling 1,051 shares during the quarter. Bronfman E.L. Rothschild L.P.’s holdings in Snap-on were worth $100,000 at the end of the most recent reporting period.

  • [By Rich Smith]

    Shares of toolmaker Snap-on (NYSE:SNA) jumped nearly 10% in Thursday trading, closing the day up 9.6% after reporting fiscal Q2 financials that missed analyst expectations for sales, but crushed on earnings.

Top 5 Warren Buffett Stocks To Buy For 2019

All the doom and gloom surrounding Apple Inc. (NASDAQ:AAPL), which centers primarily on weak demand for its flagship iPhone X and the growing saturation in the smartphone market, hasn’t fazed one famed investor. Berkshire Hathaway (NYSE:BRK-A) (NYSE:BRK-B) CEO Warren Buffett, who is arguably one of the most well-known and successful investors of all time, has continued to buy massive caches of the iPhone maker’s stock.

Buffett added a mind-boggling 75 million Apple shares last quarter — on top of the 165.3 million shares Berkshire already owned — increasing its share count by a whopping 45%. That brings the company’s total stake in Apple up to about 5% of shares.

If the naysayers are right, why does the Oracle of Omaha continue stocking up on Apple’s shares?

Warren Buffett is loading up on Apple stock. Image source: The Motley Fool.

A short history

In case you haven’t been following along, it wasn’t Buffett but rather one of his top lieutenants who first purchased Apple stock in early 2016. After reviewing that initial purchase, Buffett himself began loading up on Apple shares, buying considerably more during the quarter, with purchases totaling 10 million shares.

Top 5 Warren Buffett Stocks To Buy For 2019: Freshpet, Inc.(FRPT)

Advisors’ Opinion:

  • [By Max Byerly]

    Shares of Freshpet Inc (NASDAQ:FRPT) have been assigned a consensus rating of “Buy” from the eleven research firms that are presently covering the firm, Marketbeat Ratings reports. Five analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and two have given a strong buy recommendation to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $20.60.

  • [By Peter Graham]

    A long term performance chart shows shares of Petmed Express and pet stock peerCentral Garden & Pet Co (NASDAQ: CENT) being outstanding performers over the last year or two while pet food stocks Blue Buffalo Pet Products Inc (NASDAQ: BUFF) and Freshpet Inc (NASDAQ: FRPT) have not yet lived up to investor expectations:

  • [By Ethan Ryder]

    Freshpet Inc (NASDAQ:FRPT) reached a new 52-week high and low during trading on Tuesday . The company traded as low as $22.75 and last traded at $22.65, with a volume of 5950 shares trading hands. The stock had previously closed at $22.35.

  • [By Lisa Levin]

    On Friday, the consumer staples shares surged 0.62 percent. Meanwhile, top gainers in the sector included Universal Corporation (NYSE: UVV), up 5 percent, and Freshpet, Inc. (NASDAQ: FRPT) up 4 percent.

  • [By Logan Wallace]

    Freshpet (NASDAQ:FRPT) – Research analysts at William Blair reduced their Q2 2018 earnings estimates for shares of Freshpet in a research note issued to investors on Monday, May 7th. William Blair analyst J. Andersen now expects that the company will post earnings per share of ($0.09) for the quarter, down from their prior forecast of ($0.04). William Blair also issued estimates for Freshpet’s Q4 2018 earnings at $0.10 EPS and FY2018 earnings at ($0.07) EPS.

Top 5 Warren Buffett Stocks To Buy For 2019: Eagle Bancorp Montana, Inc.(EBMT)

Advisors’ Opinion:

  • [By Logan Wallace]

    News coverage about Eagle Bancorp Montana (NASDAQ:EBMT) has trended somewhat positive on Saturday, according to Accern Sentiment. The research firm identifies positive and negative news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Eagle Bancorp Montana earned a news sentiment score of 0.07 on Accern’s scale. Accern also gave news articles about the bank an impact score of 45.1226009264191 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Eagle Bancorp Montana (EBMT)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Warren Buffett Stocks To Buy For 2019: New York Mortgage Trust Inc.(NYMT)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Shares of NY Mtg Tr Inc/SH (NASDAQ:NYMT) have earned an average recommendation of “Hold” from the eight research firms that are presently covering the stock, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell recommendation, four have issued a hold recommendation and one has given a buy recommendation to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $6.06.

Top 5 Warren Buffett Stocks To Buy For 2019: Life Storage, Inc. (LSI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Life Storage (LSI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Life Storage (NYSE: LSI) is one of 233 public companies in the “Real estate investment trusts” industry, but how does it contrast to its competitors? We will compare Life Storage to similar businesses based on the strength of its profitability, institutional ownership, valuation, dividends, analyst recommendations, risk and earnings.

  • [By Ethan Ryder]

    Life Storage, Inc. (NYSE:LSI) President Kenneth F. Myszka sold 10,000 shares of the stock in a transaction that occurred on Monday, May 7th. The shares were sold at an average price of $91.02, for a total value of $910,200.00. The transaction was disclosed in a filing with the SEC, which is available at this link.

  • [By Joseph Griffin]

    Life Storage Inc (NYSE:LSI) – Investment analysts at Jefferies Group lifted their FY2018 EPS estimates for shares of Life Storage in a note issued to investors on Monday, June 4th. Jefferies Group analyst G. Hoglund now anticipates that the real estate investment trust will earn $5.38 per share for the year, up from their prior estimate of $5.34. Jefferies Group has a “Hold” rating and a $82.00 price target on the stock. Jefferies Group also issued estimates for Life Storage’s FY2019 earnings at $5.57 EPS.

Top 5 Warren Buffett Stocks To Buy For 2019: Great Southern Bancorp, Inc.(GSBC)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Great Southern Bancorp (GSBC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Heal Care Stocks To Own Right Now

Analysts expect that Silicon Motion (NASDAQ:SIMO) will post $0.65 earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made estimates for Silicon Motion’s earnings, with the lowest EPS estimate coming in at $0.47 and the highest estimate coming in at $0.70. Silicon Motion posted earnings of $0.70 per share during the same quarter last year, which would indicate a negative year over year growth rate of 7.1%. The company is scheduled to announce its next quarterly earnings results on Thursday, April 26th.

According to Zacks, analysts expect that Silicon Motion will report full year earnings of $3.30 per share for the current year, with EPS estimates ranging from $3.27 to $3.36. For the next year, analysts anticipate that the company will post earnings of $3.49 per share, with EPS estimates ranging from $1.93 to $4.00. Zacks’ EPS calculations are a mean average based on a survey of sell-side research analysts that cover Silicon Motion.

Top 5 Heal Care Stocks To Own Right Now: Northrop Grumman Corporation(NOC)

Advisors’ Opinion:

  • [By ]

    Cramer and Moreno next looked at Northrop Grumman (NOC) . Shares have behaved better than Boeing amid concerns over a potential trade war with China. The stock sold off with everything else in February, but quickly bounced back to new highs. For the past couple of months, the stock has been trading sideways between $336 and $359. Now, Moreno’s methodology here is to look at the height of the channel, then use that to come up with a projection of where the stock might be headed. On a breakout to the upside, he could see Northrop Grumman going to $383, up $32 from where it’s now trading. On a breakdown, though, it could sink to $312.

  • [By Todd Shriber, ETF Professor]

    Code Pink takes issue with BlackRock's investments in aerospace and defense companies such as General Dynamics Corp.(NYSE: GD), Lockheed Martin Corp. (NYSE: LMT) and Northrop Grumman Corp. (NYSE: NOC).

  • [By Lou Whiteman]

    Defense stocks enjoyed impressive gains in 2017, with Raytheon (NYSE:RTN), up 32%, and Northrop Grumman (NYSE:NOC), up 31.9%, two of the highest fliers. This year, however, has been a different story, with each company down about 4% year to date and down more than 10% since mid-April.

Top 5 Heal Care Stocks To Own Right Now: Ellie Mae, Inc.(ELLI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Ellie Mae (ELLI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Schwab Charles Investment Management Inc. boosted its stake in shares of Ellie Mae Inc (NYSE:ELLI) by 3.7% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 166,934 shares of the software maker’s stock after purchasing an additional 5,916 shares during the period. Schwab Charles Investment Management Inc.’s holdings in Ellie Mae were worth $15,348,000 at the end of the most recent reporting period.

  • [By Dan Caplinger]

    Investors are scared about the state of the mortgage market, and that’s created consternation about mortgage software platform provider Ellie Mae (NYSE:ELLI) and its ability to keep producing the huge growth that it has seen in recent years. Concerns about rising interest rates have been around for a year now, but only recently have rate increases from the Federal Reserve on the short-term end of the yield curve actually started to have a substantial upward impact on longer-term fixed mortgage rates.

  • [By Matthew Cochrane]

    Another big deal announced by First Data during the conference call was the exclusive right to process payments for the mortgage software platform powered by Ellie Mae (NYSE:ELLI). All future appraisal and application fees collected by Ellie Mae will be facilitated by First Data. Ellie Mae’s software processes more than a third of all mortgage loan applications in the U.S.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Ellie Mae (ELLI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Heal Care Stocks To Own Right Now: Trustmark Corporation(TRMK)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Trustmark (NASDAQ: TRMK) and Valley National Bank (NYSE:VLY) are both mid-cap finance companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, valuation, dividends, risk and earnings.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Trustmark (TRMK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Rhumbline Advisers lowered its position in Trustmark Corp (NASDAQ:TRMK) by 5.9% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 122,924 shares of the financial services provider’s stock after selling 7,773 shares during the quarter. Rhumbline Advisers owned about 0.18% of Trustmark worth $3,830,000 at the end of the most recent quarter.

Top 5 Heal Care Stocks To Own Right Now: Freshpet, Inc.(FRPT)

Advisors’ Opinion:

  • [By Lisa Levin]

    On Friday, the consumer staples shares surged 0.62 percent. Meanwhile, top gainers in the sector included Universal Corporation (NYSE: UVV), up 5 percent, and Freshpet, Inc. (NASDAQ: FRPT) up 4 percent.

  • [By Max Byerly]

    Shares of Freshpet Inc (NASDAQ:FRPT) have been assigned a consensus rating of “Buy” from the eleven research firms that are presently covering the firm, Marketbeat Ratings reports. Five analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and two have given a strong buy recommendation to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $20.60.

  • [By Logan Wallace]

    Freshpet (NASDAQ:FRPT) – Research analysts at William Blair reduced their Q2 2018 earnings estimates for shares of Freshpet in a research note issued to investors on Monday, May 7th. William Blair analyst J. Andersen now expects that the company will post earnings per share of ($0.09) for the quarter, down from their prior forecast of ($0.04). William Blair also issued estimates for Freshpet’s Q4 2018 earnings at $0.10 EPS and FY2018 earnings at ($0.07) EPS.

  • [By Peter Graham]

    A long term performance chart shows shares of Petmed Express and pet stock peerCentral Garden & Pet Co (NASDAQ: CENT) being outstanding performers over the last year or two while pet food stocks Blue Buffalo Pet Products Inc (NASDAQ: BUFF) and Freshpet Inc (NASDAQ: FRPT) have not yet lived up to investor expectations:

  • [By Ethan Ryder]

    Freshpet Inc (NASDAQ:FRPT) reached a new 52-week high and low during trading on Tuesday . The company traded as low as $22.75 and last traded at $22.65, with a volume of 5950 shares trading hands. The stock had previously closed at $22.35.

Top 5 Heal Care Stocks To Own Right Now: L-3 Communications Holdings, Inc.(LLL)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on L3 Technologies (LLL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lou Whiteman]

    L-3 Technologies (NYSE:LLL) missed out on much of the rally enjoyed by other defense contractors over the last year. The reason for the lagging performance was because the company was in the middle of a transformation plan aimed at propelling it into the ranks of those larger rivals. Judging by its first-quarter results, the efforts are already beginning to show results.

  • [By ]

    The primary companies identified fitting the bill are Hubbell (NYSE: HUBB), Roper Technologies (NYSE: ROP), and L3 (NYSE: LLL).

    2. Short Semiconductors
    Domestic companies with high exposure to the Chinese market are in danger due to the proposed tariffs. High technology is on the top of the sector list with Chinese exposure. Digging deeper into the high tech sector, semiconductor companies have the highest Chinese exposure.

  • [By Max Byerly]

    Shares of L3 Technologies (NYSE:LLL) have received a consensus recommendation of “Buy” from the fourteen analysts that are presently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating on the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $223.00.

  • [By Logan Wallace]

    NEXT Financial Group Inc purchased a new position in shares of L3 Technologies Inc (NYSE:LLL) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 978 shares of the aerospace company’s stock, valued at approximately $203,000.

  • [By Shane Hupp]

    Prudential Financial Inc. decreased its stake in L3 Technologies (NYSE:LLL) by 20.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 87,847 shares of the aerospace company’s stock after selling 21,981 shares during the quarter. Prudential Financial Inc. owned approximately 0.11% of L3 Technologies worth $18,272,000 as of its most recent SEC filing.